Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CPXM1 | Human | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | o and p'-DDT results in increased expression of CPXM1 mRNA | CTD | PMID:24096037 | CPXM1 | Human | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | o and p'-DDT results in increased expression of CPXM1 mRNA | CTD | PMID:24096037 | CPXM1 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CPXM1 mRNA | CTD | PMID:22206623 | CPXM1 | Human | 17alpha-ethynylestradiol | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in decreased expression of CPXM1 mRNA | CTD | PMID:17557909 | CPXM1 | Human | 17beta-estradiol | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Estradiol results in increased expression of CPXM1 mRNA | CTD | PMID:19484750 | CPXM1 | Human | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | CPXM1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPXM1 mRNA | CTD | PMID:16962184 more ... | CPXM1 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Cpxm1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | CPXM1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CPXM1 mRNA | CTD | PMID:21179406 | CPXM1 | Human | 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of CPXM1 mRNA | CTD | PMID:15205334 | CPXM1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of CPXM1 mRNA | CTD | PMID:22504374 and PMID:24780913 | CPXM1 | Human | acetamide | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CPXM1 mRNA | CTD | PMID:31881176 | CPXM1 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of CPXM1 mRNA | CTD | PMID:32763439 | CPXM1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CPXM1 mRNA | CTD | PMID:33167477 | CPXM1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CPXM1 mRNA | CTD | PMID:33212167 | CPXM1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CPXM1 3' UTR more ... | CTD | PMID:27901495 | CPXM1 | Human | bisphenol A | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CPXM1 mRNA | CTD | PMID:25181051 and PMID:34947998 | CPXM1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CPXM1 mRNA | CTD | PMID:27685785 | CPXM1 | Human | buta-1,3-diene | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of CPXM1 mRNA | CTD | PMID:29038090 | CPXM1 | Human | cadmium atom | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPXM1 mRNA | CTD | PMID:37325564 | CPXM1 | Human | cadmium dichloride | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPXM1 mRNA | CTD | PMID:37325564 | CPXM1 | Human | carbon nanotube | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CPXM1 | Human | choline | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPXM1 mRNA | CTD | PMID:20938992 | CPXM1 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CPXM1 mRNA | CTD | PMID:27594783 | CPXM1 | Human | cyclosporin A | decreases methylation | EXP | | 6480464 | Cyclosporine results in decreased methylation of CPXM1 promoter | CTD | PMID:27989131 | CPXM1 | Human | dibutyl phthalate | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of CPXM1 mRNA | CTD | PMID:21266533 | CPXM1 | Human | dimethylarsinic acid | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA | CTD | PMID:34876320 | CPXM1 | Human | dimethylarsinic acid | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Cacodylic Acid results in decreased expression of CPXM1 mRNA | CTD | PMID:37567419 | CPXM1 | Human | dioxygen | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPXM1 mRNA | CTD | PMID:30529165 | CPXM1 | Human | diquat | decreases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Diquat results in decreased expression of CPXM1 mRNA | CTD | PMID:36851058 | CPXM1 | Human | diuron | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of CPXM1 mRNA | CTD | PMID:25152437 | CPXM1 | Human | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of CPXM1 mRNA | CTD | PMID:15205334 | CPXM1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CPXM1 mRNA | CTD | PMID:29803840 | CPXM1 | Human | endosulfan | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of CPXM1 mRNA | CTD | PMID:29391264 | CPXM1 | Human | folic acid | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPXM1 mRNA | CTD | PMID:20938992 | CPXM1 | Human | furan | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | furan results in increased expression of CPXM1 mRNA | CTD | PMID:27387713 | CPXM1 | Human | furan | decreases methylation | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | furan results in decreased methylation of CPXM1 gene | CTD | PMID:27387713 | CPXM1 | Human | genistein | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Genistein results in increased expression of CPXM1 mRNA | CTD | PMID:32186404 | CPXM1 | Human | gentamycin | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CPXM1 mRNA | CTD | PMID:33387578 | CPXM1 | Human | inulin | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CPXM1 mRNA | CTD | PMID:36331819 | CPXM1 | Human | L-methionine | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPXM1 mRNA | CTD | PMID:20938992 | CPXM1 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of CPXM1 mRNA | CTD | PMID:28903495 | CPXM1 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CPXM1 mRNA] | CTD | PMID:35811015 | CPXM1 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of CPXM1 mRNA | CTD | PMID:35811015 | CPXM1 | Human | methimazole | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of CPXM1 mRNA | CTD | PMID:22504374 | CPXM1 | Human | methylarsonic acid | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA | CTD | PMID:34876320 | CPXM1 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CPXM1 mRNA | CTD | PMID:20061341 and PMID:25566086 | CPXM1 | Human | ozone | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CPXM1 mRNA | CTD | PMID:34911549 | CPXM1 | Human | paracetamol | affects expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CPXM1 mRNA | CTD | PMID:17562736 | CPXM1 | Human | paracetamol | decreases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of CPXM1 mRNA | CTD | PMID:33387578 | CPXM1 | Human | paraquat | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of CPXM1 mRNA | CTD | PMID:32680482 | CPXM1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CPXM1 mRNA | CTD | PMID:36331819 | CPXM1 | Human | pioglitazone | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CPXM1 mRNA | CTD | PMID:27935865 | CPXM1 | Human | pirinixic acid | decreases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CPXM1 mRNA | CTD | PMID:23811191 | CPXM1 | Human | progesterone | affects expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Progesterone affects the expression of CPXM1 mRNA | CTD | PMID:17251523 | CPXM1 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CPXM1 mRNA] | CTD | PMID:35811015 | CPXM1 | Human | silicon dioxide | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CPXM1 mRNA | CTD | PMID:29341224 | CPXM1 | Human | sodium arsenate | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA | CTD | PMID:34876320 | CPXM1 | Human | sodium arsenite | decreases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CPXM1 mRNA | CTD | PMID:18812580 | CPXM1 | Human | sodium arsenite | multiple interactions | ISO | Cpxm1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA | CTD | PMID:34876320 | CPXM1 | Human | sodium arsenite | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CPXM1 mRNA | CTD | PMID:37682722 | CPXM1 | Human | Soman | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Soman results in increased expression of CPXM1 mRNA | CTD | PMID:19281266 | CPXM1 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CPXM1 mRNA | CTD | PMID:31533062 | CPXM1 | Human | titanium dioxide | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CPXM1 mRNA | CTD | PMID:23557971 | CPXM1 | Human | titanium dioxide | increases methylation | ISO | Cpxm1 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CPXM1 gene | CTD | PMID:35295148 | CPXM1 | Human | trichloroethene | increases expression | ISO | Cpxm1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CPXM1 mRNA | CTD | PMID:33387578 | CPXM1 | Human | trimellitic anhydride | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of CPXM1 mRNA | CTD | PMID:19042947 | CPXM1 | Human | triptonide | increases expression | ISO | Cpxm1 (Mus musculus) | 6480464 | triptonide results in increased expression of CPXM1 mRNA | CTD | PMID:33045310 | CPXM1 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CPXM1 gene | CTD | PMID:29154799 | |